BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6208041)

  • 1. A pharmacological study with substance K: evidence for multiple types of tachykinin receptors.
    Hunter JC; Maggio JE
    Eur J Pharmacol; 1984 Oct; 105(1-2):149-53. PubMed ID: 6208041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists.
    Mizrahi J; Dion S; D'Orléans-Juste P; Escher E; Drapeau G; Regoli D
    Eur J Pharmacol; 1985 Nov; 118(1-2):25-36. PubMed ID: 2417867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel selective agonists and antagonists confirm neurokinin NK1 receptors in guinea-pig vas deferens.
    Hall JM; Morton IK
    Br J Pharmacol; 1991 Feb; 102(2):511-7. PubMed ID: 1707714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder.
    Burcher E; Buck SH; Lovenberg W; O'Donohue TL
    J Pharmacol Exp Ther; 1986 Mar; 236(3):819-31. PubMed ID: 2419545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of peptide and non-peptide antagonists at peripheral NK1 receptors.
    Patacchini R; Santicioli P; Astolfi M; Rovero P; Viti G; Maggi CA
    Eur J Pharmacol; 1992 Apr; 215(1):93-8. PubMed ID: 1381319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FR 113680: a novel tripeptide substance P antagonist with NK1 receptor selectivity.
    Morimoto H; Murai M; Maeda Y; Hagiwara D; Miyake H; Matsuo M; Fujii T
    Br J Pharmacol; 1992 May; 106(1):123-6. PubMed ID: 1380378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An examination of the pharmacology of two substance P antagonists and the evidence for tachykinin receptor subtypes.
    Bailey SJ; Featherstone RL; Jordan CC; Morton IK
    Br J Pharmacol; 1986 Jan; 87(1):79-85. PubMed ID: 2420403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder.
    Hall JM; Flowers JM; Morton IK
    Br J Pharmacol; 1992 Nov; 107(3):777-84. PubMed ID: 1282072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacological profile of a substance P (SP) antagonist. Evidence for the existence of subpopulations of SP receptors.
    Rosell S; Björkroth U; Xu JC; Folkers K
    Acta Physiol Scand; 1983 Mar; 117(3):445-9. PubMed ID: 6192681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple tachykinin binding sites in hamster, rat and guinea-pig urinary bladder.
    Burcher E; Buck SH
    Eur J Pharmacol; 1986 Sep; 128(3):165-77. PubMed ID: 3024992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tachykinin antagonists: substitutions in positions 5 and 6 with amino acids from the primary sequence of substance P homologues.
    Mathison R; Escher E; Huggel H; Mizrahi J; Regoli D
    Eur J Pharmacol; 1985 Aug; 114(2):147-55. PubMed ID: 2412854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further evidence for multiple tachykinin receptors.
    Growcott JW; Jamieson A; Tarpey AV; Topham LD
    Eur J Pharmacol; 1982 Dec; 86(1):59-64. PubMed ID: 6186499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the effects of three substance P antagonists on tachykinin-stimulated [3H]-acetylcholine release in the guinea-pig ileum.
    Featherstone RL; Fosbraey P; Morton IK
    Br J Pharmacol; 1986 Jan; 87(1):73-7. PubMed ID: 2420402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of spantide I and II at various tachykinin receptors and NK-2 tachykinin receptor subtypes.
    Maggi CA; Patacchini R; Feng DM; Folkers K
    Eur J Pharmacol; 1991 Jun; 199(1):127-9. PubMed ID: 1716573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptors for mammalian tachykinins on isolated intestinal smooth muscle cells.
    Souquet JC; Grider JR; Bitar KN; Makhlouf GM
    Am J Physiol; 1985 Oct; 249(4 Pt 1):G533-8. PubMed ID: 2413771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
    Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
    Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site.
    Cascieri MA; Chicchi GG; Freidinger RM; Colton CD; Perlow DS; Williams B; Curtis NR; McKnight AT; Maguire JJ; Veber DF
    Mol Pharmacol; 1986 Jan; 29(1):34-8. PubMed ID: 2418347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptors for substance P on isolated intestinal smooth muscle cells of the guinea pig.
    Souquet JC; Bitar KN; Grider JR; Makhlouf GM
    Am J Physiol; 1987 Nov; 253(5 Pt 1):G666-72. PubMed ID: 2446507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tachykinin NK1 receptor subtypes in the rat urinary bladder.
    Meini S; Patacchini R; Maggi CA
    Br J Pharmacol; 1994 Mar; 111(3):739-46. PubMed ID: 7517327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Leu9 psi(CH2NH)Leu10]-neurokinin A (4-10) (MDL 28,564) distinguishes tissue tachykinin peptide NK2 receptors.
    Buck SH; Harbeson SL; Hassmann CF; Shatzer SA; Rouissi N; Nantel F; van Giersbergen PL
    Life Sci; 1990; 47(10):PL37-41. PubMed ID: 2170788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.